close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk ↗
Via Investor's Business Daily
Topics Lawsuit
Tickers LLY
Exposures Financial Legal Product Safety
News headline image
Medtronic (MDT) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
Tickers MDT
Exposures COVID-19 Financial Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRX-100 NDA Pathway
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
News headline image
Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
Via Finterra
Topics Economy Intellectual Property
Tickers BNTX GSK MRK MRNA PFE SNY
Exposures COVID-19 Intellectual Property Interest Rates
News headline image
Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot
Via Finterra
Topics Artificial Intelligence Earnings Supply Chain
Tickers A BLK DHR FTV MASI NVST
Exposures Artificial Intelligence COVID-19 Financial
News headline image
Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum
Via Finterra
Topics Artificial Intelligence Earnings Economy
Tickers ABT BSX GS ISRG JPM MDT
Exposures Artificial Intelligence Financial Interest Rates
News headline image
Shopify's Whiplash Day ↗
Via The Motley Fool
Tickers AMZN BA CROX GE GOOG GOOGL
Exposures Product Safety
News headline image
Federal Health Expert Launches Telehealth Platform That’s Disrupting the $75+ Online Doctor Visit
Via AB Newswire
Exposures Product Safety
News headline image
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Via Newsfile
Tickers ASX:COH COCH
Exposures Product Safety
News headline image
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
Via NewMediaWire
Topics Intellectual Property
Tickers NMTC
Exposures Intellectual Property Product Safety
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
Via TheNewswire.com
Topics Intellectual Property
Tickers NMTC
Exposures Intellectual Property Product Safety
News headline image
FDA Delays Disc Medicine's Rare Disease Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
Via Stocktwits
Tickers ARKG CMPS IBB PSIL
Exposures Product Safety
News headline image
The Top 5 Analyst Questions From Incyte’s Q4 Earnings Call
Via StockStory
Topics Earnings
Tickers INCY
Exposures Financial Product Safety
News headline image
Anktiva Vs Keytruda: ImmunityBio Exec Chair Slams FDA For Double Standards In Approvals ↗
Via Stocktwits
Tickers IBRX MRK
Exposures Product Safety
News headline image
OCUL Stock Surges Overnight Ahead Of Crucial Wet AMD Data Readout, Sanofi Takeover Buzz Builds ↗
Via Stocktwits
Tickers AMD BAC OCUL
Exposures Product Safety
News headline image
Robert Kennedy Jr Says FDA Lost Track Of Food Ingredients, No Way For Americans To Know If 'Ultra Processed' Food Safe ↗
Via Benzinga
Exposures Product Safety
News headline image
U.S. Marine finds relief after years‑long battle with high blood pressure
Via NewsUSA
Topics Product Recall
Exposures Legal Product Safety
News headline image
Matthew West-James’ new book receives a warm literary welcome
Via Get News
Topics Product Recall
Exposures Legal Product Safety
News headline image
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
Via MarketMinute
Topics Intellectual Property
Tickers ALPMY AZN BMY CGON JNJ MRK
Exposures Intellectual Property Product Safety
News headline image
Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom
Via MarketMinute
Tickers OCUL REGN SNY VRTX
Exposures Product Safety
News headline image
Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data
Via MarketMinute
Tickers ADVM AMD BAYRY EYPT OCUL REGN
Exposures Product Safety
News headline image
Got $300? 2 Biotech Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Tickers KRYS SPRY
Exposures Product Safety
News headline image
FDA Detects Toxic Patulin Levels In Tippy Toes Baby Food, Prompting Recall ↗
Via Benzinga
Tickers AAPL
Exposures Product Safety
News headline image
MRNA Q4 Deep Dive: New Vaccines, Cost Controls, and Pipeline Milestones Shape Outlook
Via StockStory
Tickers MRNA
Exposures COVID-19 Product Safety
News headline image
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU ↗
Via Stocktwits
Tickers IBRX VTI XBI
Exposures Product Safety
News headline image
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives ↗
Via Stocktwits
Topics Workforce
Tickers HOWL VTI VXF
Exposures Layoff Product Safety
News headline image
Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
Via MarketMinute
Topics Earnings
Tickers GSK MRK MRNA PFE
Exposures COVID-19 Financial Product Safety
News headline image
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns ↗
Via Stocktwits
Tickers IRON IWM VTI
Exposures Product Safety
News headline image
Beyond Air XAIR Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers XAIR
Exposures Financial Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today